Western blot analysis showed that neutrophil gelatinase-associated lipocalin (NGAL), one of the best markers of AKI, was significantly less in kidneys from the cisplatin + SHD group compared to those from the cisplatin group (Figures 5F,G). The gene discussed is LCN2; the disease is acute kidney injury.